Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM.

Eur Respir J. 2018 Nov 8. pii: 1801687. doi: 10.1183/13993003.01687-2018. [Epub ahead of print] No abstract available.

PMID:
30409820
2.

Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.

Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM, Adarraga MD, Mastroiacovo D, Konstantinides SV, Monreal M; RIETE Investigators.

Thromb Res. 2018 Sep 27. pii: S0049-3848(18)30547-4. doi: 10.1016/j.thromres.2018.09.056. [Epub ahead of print]

PMID:
30385047
3.

Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis.

Barco S, Ende-Verhaar YM, Becattini C, Jimenez D, Lankeit M, Huisman MV, Konstantinides SV, Klok FA.

Eur Heart J. 2018 Oct 17. doi: 10.1093/eurheartj/ehy631. [Epub ahead of print]

PMID:
30339253
4.

Performance of idarucizumab as antidote of dabigatran in daily clinical practice.

van der Wall SJ, van Rein N, van den Bemt B, Kruip MJHA, Meijer K, Te Boome LCJ, Simmers TA, Alings AMW, Tieleman R, Klok FA, Huisman MV.

Europace. 2018 Oct 17. doi: 10.1093/europace/euy220. [Epub ahead of print]

PMID:
30339226
5.

Safety of D-dimer as a stand-alone test for the exclusion of deep vein thrombosis compared to other strategies.

Fronas SG, Wik HS, Dahm A, Jørgensen CT, Gleditsch J, Raouf N, Klok FA, Ghanima W.

J Thromb Haemost. 2018 Oct 10. doi: 10.1111/jth.14314. [Epub ahead of print]

PMID:
30303610
6.

The impact of post-pulmonary embolism syndrome and its possible determinants.

Tavoly M, Wik HS, Sirnes PA, Jelsness-Jørgensen LP, Ghanima JP, Klok FA, Sandset PM, Ghanima W.

Thromb Res. 2018 Sep 15;171:84-91. doi: 10.1016/j.thromres.2018.09.048. [Epub ahead of print]

PMID:
30267974
7.

Determining the minimal clinically important difference for the PEmbQoL questionnaire, a measure of pulmonary embolism-specific quality of life.

Akaberi A, Klok FA, Cohn DM, Hirsch A, Granton J, Kahn SR.

J Thromb Haemost. 2018 Sep 21. doi: 10.1111/jth.14302. [Epub ahead of print]

PMID:
30240543
8.

Correction to: Antithrombotic therapy after mitral valve repair: VKA or aspirin?

van der Wall SJ, Olsthoorn JR, Heuts S, Klautz RJM, Tomsic A, Jansen EK, Vonk ABA, Sardari Nia P, Klok FA, Huisman MV.

J Thromb Thrombolysis. 2018 Nov;46(4):482. doi: 10.1007/s11239-018-1735-x.

PMID:
30203248
9.

Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm.

van der Pol LM, Bistervels IM, van Mens TE, van der Hulle T, Beenen LFM, den Exter PL, Kroft LJM, Mairuhu ATA, Middeldorp S, van Werkhoven JM, Ten Wolde M, Huisman MV, Klok FA.

Br J Haematol. 2018 Sep 10. doi: 10.1111/bjh.15556. [Epub ahead of print]

PMID:
30198551
10.

Antithrombotic therapy after mitral valve repair: VKA or aspirin?

van der Wall SJ, Olsthoorn JR, Heuts S, Klautz RJM, Tomsic A, Jansen EK, Vonk ABA, Sardari Nia P, Klok FA, Huisman MV.

J Thromb Thrombolysis. 2018 Nov;46(4):473-481. doi: 10.1007/s11239-018-1724-0. Erratum in: J Thromb Thrombolysis. 2018 Sep 10;:.

11.

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.

Klok FA, Barco S, Turpie AGG, Haas S, Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides SV, Ageno W.

Br J Haematol. 2018 Aug 19. doi: 10.1111/bjh.15533. [Epub ahead of print]

PMID:
30123981
12.

Computed tomography pulmonary angiography versus ventilation-perfusion lung scan for pulmonary embolism diagnosis during pregnancy: a systematic review and meta-analysis.

Tromeur C, van der Pol LM, Le Roux PY, Ende-Verhaar Y, Salaun PY, Leroyer C, Couturaud F, Kroft LJM, Huisman MV, Klok FA.

Haematologica. 2018 Aug 16. pii: haematol.2018.196121. doi: 10.3324/haematol.2018.196121. [Epub ahead of print]

13.

Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Ende-Verhaar YM, van den Hout WB, Bogaard HJ, Meijboom LJ, Huisman MV, Symersky P, Vonk-Noordegraaf A, Klok FA.

J Thromb Haemost. 2018 Nov;16(11):2168-2174. doi: 10.1111/jth.14266. Epub 2018 Aug 30.

PMID:
30099844
14.

Home treatment of acute pulmonary embolism: state of the art in 2018.

van der Wall SJ, Hendriks SV, Huisman MV, Klok FA.

Curr Opin Pulm Med. 2018 Sep;24(5):425-431. doi: 10.1097/MCP.0000000000000512.

PMID:
30020141
15.

Management and treatment of deep vein thrombosis in special populations.

Boon GJAM, Van Dam LF, Klok FA, Huisman MV.

Expert Rev Hematol. 2018 Sep;11(9):685-695. doi: 10.1080/17474086.2018.1502082. Epub 2018 Jul 25.

PMID:
30016119
16.

Pharmacological properties of betrixaban.

Huisman MV, Klok FA.

Eur Heart J Suppl. 2018 May;20(Suppl E):E12-E15. doi: 10.1093/eurheartj/suy016. Epub 2018 May 9.

17.

Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism.

Huisman MV, Ferreira M, Feuring M, Fraessdorf M, Klok FA.

J Thromb Haemost. 2018 Sep;16(9):1775-1778. doi: 10.1111/jth.14226. Epub 2018 Aug 11.

PMID:
29974611
18.

Predicting Post-Thrombotic Syndrome with Ultrasonographic Follow-Up after Deep Vein Thrombosis: A Systematic Review and Meta-Analysis.

Dronkers CEA, Mol GC, Maraziti G, van de Ree MA, Huisman MV, Becattini C, Klok FA.

Thromb Haemost. 2018 Aug;118(8):1428-1438. doi: 10.1055/s-0038-1666859. Epub 2018 Jul 4.

PMID:
29972864
19.

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A.

BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20.

PMID:
29940089
20.

Novel Anticoagulant Treatment for Pulmonary Embolism with Direct Oral Anticoagulants Phase 3 Trials and Clinical Practice.

Tromeur C, van der Pol LM, Mairuhu ATA, Leroyer C, Couturaud F, Huisman MV, Klok FA.

Semin Intervent Radiol. 2018 Jun;35(2):83-91. doi: 10.1055/s-0038-1642622. Epub 2018 Jun 4. Review.

PMID:
29872242
21.

Persistence to direct oral anticoagulants for acute venous thromboembolism.

Dronkers CEA, Lijfering WM, Teichert M, van der Meer FJM, Klok FA, Cannegieter SC, Huisman MV.

Thromb Res. 2018 May 19;167:135-141. doi: 10.1016/j.thromres.2018.05.013. [Epub ahead of print]

PMID:
29843087
22.

Pulmonary embolism.

Huisman MV, Barco S, Cannegieter SC, Le Gal G, Konstantinides SV, Reitsma PH, Rodger M, Vonk Noordegraaf A, Klok FA.

Nat Rev Dis Primers. 2018 May 17;4:18028. doi: 10.1038/nrdp.2018.28. Review.

PMID:
29770793
23.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment.

Kraaijpoel N, Toorop MMA, Bossuyt PM, Klok FA, Büller HR, van Es N.

J Thromb Haemost. 2018 Jul;16(7):1445-1448. doi: 10.1111/jth.14133. Epub 2018 Jun 12. No abstract available.

PMID:
29733495
24.

Clinical effects of antiplatelet drugs and statins on D-dimer levels.

Schol-Gelok S, van der Hulle T, Biedermann JS, van Gelder T, Klok FA, van der Pol LM, Versmissen J, Huisman MV, Kruip MJHA.

Eur J Clin Invest. 2018 Jul;48(7):e12944. doi: 10.1111/eci.12944. Epub 2018 May 13.

25.

Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism.

Klok FA, Delcroix M, Bogaard HJ.

J Thromb Haemost. 2018 Jun;16(6):1040-1051. doi: 10.1111/jth.14016. Epub 2018 May 8. Review.

PMID:
29608809
26.

Follow-up after acute Pulmonary Embolism.

Klok FA, Barco S.

Hamostaseologie. 2018 Feb;38(1):22-32. doi: 10.5482/HAMO-17-06-0020. Epub 2018 Feb 26.

PMID:
29536477
27.

Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism.

Klok FA, Barco S, Konstantinides SV.

Eur Respir J. 2018 Apr 19;51(4). pii: 1800077. doi: 10.1183/13993003.00077-2018. Print 2018 Apr. No abstract available.

PMID:
29496756
28.

Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism.

van Mens TE, van der Pol LM, van Es N, Bistervels IM, Mairuhu ATA, van der Hulle T, Klok FA, Huisman MV, Middeldorp S.

J Thromb Haemost. 2018 May;16(5):858-865. doi: 10.1111/jth.13984. Epub 2018 Mar 22.

PMID:
29460484
29.

The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department.

van der Pol LM, Dronkers CEA, van der Hulle T, den Exter PL, Tromeur C, Heringhaus C, Mairuhu ATA, Huisman MV, van den Hout WB, Klok FA.

J Thromb Haemost. 2018 Apr;16(4):725-733. doi: 10.1111/jth.13972. Epub 2018 Mar 13.

PMID:
29431911
30.

Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism.

van der Pol LM, van der Hulle T, Mairuhu ATA, Huisman MV, Klok FA.

Thromb Haemost. 2018 Mar;118(3):547-552. doi: 10.1055/s-0038-1623535. Epub 2018 Feb 1.

PMID:
29390226
31.

Diagnosing upper extremity deep vein thrombosis with non-contrast-enhanced Magnetic Resonance Direct Thrombus Imaging: A pilot study.

Dronkers CEA, Klok FA, van Haren GR, Gleditsch J, Westerlund E, Huisman MV, Kroft LJM.

Thromb Res. 2018 Mar;163:47-50. doi: 10.1016/j.thromres.2018.01.015. Epub 2018 Jan 10.

PMID:
29353683
32.

Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.

Barco S, Vicaut E, Klok FA, Lankeit M, Meyer G, Konstantinides SV; PEITHO Investigators.

Eur Respir J. 2018 Jan 18;51(1). pii: 1701775. doi: 10.1183/13993003.01775-2017. Print 2018 Jan. No abstract available.

PMID:
29348184
33.

Symptomatic subsegmental pulmonary embolism: to treat or not to treat?

Carrier M, Klok FA.

Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):237-241. doi: 10.1182/asheducation-2017.1.237. Review.

PMID:
29222261
34.

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.

Klok FA, Ageno W, Barco S, Binder H, Brenner B, Duerschmied D, Empen K, Faggiano P, Ficker JH, Galiè N, Ghuysen A, Held M, Heydenreich N, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Münzel T, Petris A, Pruszczyk P, Quitzau K, Schellong S, Schmidt KH, Stefanovic BS, Verschuren F, Wolf-Puetz A, Meyer G, Konstantinides SV; PEITHO-2 Investigators.

Thromb Haemost. 2017 Dec;117(12):2425-2434. doi: 10.1160/TH17-06-0434. Epub 2017 Dec 6.

PMID:
29212130
35.

Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism.

Ende-Verhaar YM, Kroft LJM, Mos ICM, Huisman MV, Klok FA.

PLoS One. 2017 Nov 28;12(11):e0188862. doi: 10.1371/journal.pone.0188862. eCollection 2017.

36.

Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis.

Jimenez D, Martin-Saborido C, Muriel A, Zamora J, Morillo R, Barrios D, Klok FA, Huisman MV, Tapson V, Yusen RD.

Thorax. 2018 May;73(5):464-471. doi: 10.1136/thoraxjnl-2017-210040. Epub 2017 Nov 13.

PMID:
29133351
37.

Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.

den Exter PL, Hooijer J, van der Hulle T, van Oosten JP, Dekkers OM, Klok FA, Huisman MV.

Thromb Haemost. 2017 Nov 1;117(11):2163-2167. doi: 10.1160/TH-17-06-0382. Epub 2017 Oct 4.

PMID:
28981552
38.

No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism.

van der Pol LM, van der Hulle T, Cheung YW, Mairuhu ATA, Schaar CG, Faber LM, Ten Wolde M, Hofstee HMA, Hovens MMC, Nijkeuter M, van Klink RCJ, Kruip MJHA, Middeldorp S, Huisman MV, Klok FA.

J Thromb Haemost. 2017 Dec;15(12):2317-2324. doi: 10.1111/jth.13852. Epub 2017 Oct 24.

PMID:
28941051
39.

Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH.

Dronkers CEA, Ende-Verhaar YM, Kyrle PA, Righini M, Cannegieter SC, Huisman MV, Klok FA; Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.

J Thromb Haemost. 2017 Nov;15(11):2270-2273. doi: 10.1111/jth.13805. Epub 2017 Sep 18. No abstract available.

PMID:
28922557
40.
41.

[Pulmonary embolism response teams: what is the added value for patients with acute pulmonary embolism?]

Huisman MV, Montero Cabezas JM, Klok FA.

Ned Tijdschr Geneeskd. 2017;161:D1570. Dutch.

PMID:
28831930
42.

Letter by Barco et al Regarding Article, "Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis".

Barco S, Klok FA, Dentali F.

Stroke. 2017 Sep;48(9):e266. doi: 10.1161/STROKEAHA.117.018509. Epub 2017 Aug 7. No abstract available.

PMID:
28784924
43.

Management of incidental pulmonary embolism.

Klok FA, Huisman MV.

Eur Respir J. 2017 Jun 29;49(6). pii: 1700275. doi: 10.1183/13993003.00275-2017. Print 2017 Jun. Review.

PMID:
28663318
44.

Late outcomes of pulmonary embolism: The post-PE syndrome.

Sista AK, Klok FA.

Thromb Res. 2018 Apr;164:157-162. doi: 10.1016/j.thromres.2017.06.017. Epub 2017 Jun 16.

PMID:
28641836
45.

Therapeutic management of acute pulmonary embolism.

Tromeur C, Van Der Pol LM, Couturaud F, Klok FA, Huisman MV.

Expert Rev Respir Med. 2017 Aug;11(8):641-648. doi: 10.1080/17476348.2017.1338952. Epub 2017 Jun 8. Review.

PMID:
28580827
46.

Diagnosis of recurrent venous thromboembolism.

Barco S, Konstantinides S, Huisman MV, Klok FA.

Thromb Res. 2018 Mar;163:229-235. doi: 10.1016/j.thromres.2017.05.026. Epub 2017 May 26.

PMID:
28577758
47.

Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.

van der Hulle T, van Es N, den Exter PL, van Es J, Mos ICM, Douma RA, Kruip MJHA, Hovens MMC, Ten Wolde M, Nijkeuter M, Ten Cate H, Kamphuisen PW, Büller HR, Huisman MV, Klok FA.

Thromb Haemost. 2017 Jul 26;117(8):1622-1629. doi: 10.1160/TH17-02-0076. Epub 2017 Jun 1.

PMID:
28569924
48.

Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study.

van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group.

Lancet. 2017 Jul 15;390(10091):289-297. doi: 10.1016/S0140-6736(17)30885-1. Epub 2017 May 23. Erratum in: Lancet. 2017 Jul 15;390(10091):230.

PMID:
28549662
49.

Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat.

Klok FA, Hoeper MM.

Eur Respir J. 2017 May 25;49(5). pii: 1700413. doi: 10.1183/13993003.00413-2017. Print 2017 May. No abstract available.

PMID:
28546262
50.

Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis.

Squizzato A, Pomero F, Allione A, Priotto R, Riva N, Huisman MV, Klok FA, Stein PD, Guasti L, Fenoglio L, Dentali F, Ageno W.

Thromb Res. 2017 Jun;154:64-72. doi: 10.1016/j.thromres.2017.03.027. Epub 2017 Apr 7. Review.

PMID:
28427005

Supplemental Content

Support Center